Roth Capital initiates coverage on Daktronics with Buy rating
Roth Capital analyst Thomas Hayes initiated coverage on Daktronics Inc with a Buy rating and a price target of $26. Daktronics shares closed at $19.13 on Wednesday. Other initiations included coverage on Thermo Fisher Scientific, Voyager Technologies, Danaher, and Sensei Biotherapeutics.

*this image is generated using AI for illustrative purposes only.
Roth Capital analyst Thomas Hayes has initiated coverage on Daktronics Inc with a Buy rating and announced a price target of $26. The rating reflects a positive outlook on the company's performance. Daktronics shares closed at $19.13 on Wednesday.
Analyst Details
Thomas Hayes, an analyst at Roth Capital, provided the assessment. The coverage initiation highlights the firm's perspective on Daktronics' market position.
Price Target
The established price target of $26 serves as a benchmark for the stock's potential valuation.
Other Initiations
Top Wall Street analysts also changed their outlook on other names:
| Company | Analyst | Rating | Price Target | Previous Close |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | Piper Sandler (David Westenberg) | Neutral | $510 | $482.04 |
| Voyager Technologies Inc | BTIG (Andre Madrid) | Buy | $55 | $41.28 |
| Danaher Corp | Piper Sandler (David Westenberg) | Neutral | $200 | $183.63 |
| Sensei Biotherapeutics Inc | BTIG (Jeet Mukherjee) | Buy | $55 | $11.41 |
What specific factors are driving Roth Capital's bullish outlook on Daktronics?
How might Daktronics' recent performance influence investor sentiment in the display technology sector?
What are the key risks that could prevent Daktronics from reaching the $26 price target?

























